Enanta Pharmaceuticals Inc (ENTA) — Cash Flow Reinvestment Rate
Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Reinvestment Rate of 1.52x as of June 2025, reinvesting $26.64 Million (capex $155.00K plus investments $-26.48 Million) from operating cash flow of $17.51 Million. Check Enanta Pharmaceuticals Inc (ENTA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Enanta Pharmaceuticals Inc Cash Flow Reinvestment Rate (2011–2020)
Historical reinvestment intensity for Enanta Pharmaceuticals Inc across 10 annual periods. Explore Enanta Pharmaceuticals Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year capital reinvestment analysis for Enanta Pharmaceuticals Inc. For live market cap and broader valuation context, see ENTA stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.21x | $22.72 Million | $7.09 Million | $1.45 Million | ▲ +164.2% |
| 2019 | 1.21x | $86.66 Million | $71.42 Million | $5.42 Million | ▼ -7.6% |
| 2018 | 1.31x | $38.38 Million | $29.22 Million | $2.98 Million | ▲ +1412.8% |
| 2017 | 0.09x | $4.57 Million | $52.65 Million | $2.51 Million | ▼ -92.9% |
| 2016 | 1.22x | $43.66 Million | $35.81 Million | $4.74 Million | ▲ +6.2% |
| 2015 | 1.15x | $88.02 Million | $76.67 Million | $2.34 Million | ▲ +808.5% |
| 2014 | 0.13x | $2.55 Million | $20.18 Million | $1.03 Million | ▼ -98.1% |
| 2013 | 6.50x | $69.22 Million | $10.65 Million | $606.00K | ▲ +58229.0% |
| 2012 | 0.01x | $252.00K | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $445.00K | $24.02 Million | $445.00K | — |